Matches in SemOpenAlex for { <https://semopenalex.org/work/W2089925954> ?p ?o ?g. }
- W2089925954 endingPage "753" @default.
- W2089925954 startingPage "745" @default.
- W2089925954 abstract "The Renal Insufficiency and Anticancer Medications (IRMA) study is a French national, observational study which demonstrated the high prevalence of abnormal renal function in a population of 4,684 solid tumour patients. Among them, 50-60% had decreased renal function defined as CrCl below 90 and 80% were treated with anticancer drugs that either necessitated dosage adjustment in case of RI or were potentially nephrotoxic drugs. Since patients and drugs used differ depending on the type of tumour, the IRMA Study Group started analyses in different subgroups of patients. In the 1898 IRMA patients with breast cancer, the prevalence of RI was still very high in spite of a normal serum creatinine in almost all cases. Some anticancer drugs, as in particular some bisphosphonates, capecitabine and platinum salts, may be nephrotoxic and/or need dosage adjustment. However other important drugs in breast cancer do not require dose reduction, and do not present with potential nephrotoxicity (anthracyclines, taxanes, trastuzumab). Both issues seem to be slightly but significantly more important in patients with bone metastases as compared to patients with a non-metastatic disease." @default.
- W2089925954 created "2016-06-24" @default.
- W2089925954 creator A5017379947 @default.
- W2089925954 creator A5018432685 @default.
- W2089925954 creator A5020254907 @default.
- W2089925954 creator A5023282286 @default.
- W2089925954 creator A5026180389 @default.
- W2089925954 creator A5040938888 @default.
- W2089925954 creator A5044328939 @default.
- W2089925954 creator A5047019507 @default.
- W2089925954 creator A5063649167 @default.
- W2089925954 creator A5073713547 @default.
- W2089925954 creator A5086165382 @default.
- W2089925954 date "2008-08-15" @default.
- W2089925954 modified "2023-09-30" @default.
- W2089925954 title "Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues" @default.
- W2089925954 cites W147280129 @default.
- W2089925954 cites W1550111394 @default.
- W2089925954 cites W1965011371 @default.
- W2089925954 cites W1979223612 @default.
- W2089925954 cites W1982379324 @default.
- W2089925954 cites W1988303925 @default.
- W2089925954 cites W2027011799 @default.
- W2089925954 cites W2029405758 @default.
- W2089925954 cites W2043575472 @default.
- W2089925954 cites W2057737696 @default.
- W2089925954 cites W2078272044 @default.
- W2089925954 cites W2090850966 @default.
- W2089925954 cites W2097817527 @default.
- W2089925954 cites W2115871403 @default.
- W2089925954 cites W2131087743 @default.
- W2089925954 cites W2133813097 @default.
- W2089925954 cites W2135686124 @default.
- W2089925954 cites W2152409486 @default.
- W2089925954 cites W2157597826 @default.
- W2089925954 cites W2164429641 @default.
- W2089925954 cites W2165824128 @default.
- W2089925954 cites W2401709656 @default.
- W2089925954 cites W4249770406 @default.
- W2089925954 doi "https://doi.org/10.1007/s10549-008-0131-1" @default.
- W2089925954 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18704681" @default.
- W2089925954 hasPublicationYear "2008" @default.
- W2089925954 type Work @default.
- W2089925954 sameAs 2089925954 @default.
- W2089925954 citedByCount "41" @default.
- W2089925954 countsByYear W20899259542012 @default.
- W2089925954 countsByYear W20899259542013 @default.
- W2089925954 countsByYear W20899259542014 @default.
- W2089925954 countsByYear W20899259542015 @default.
- W2089925954 countsByYear W20899259542016 @default.
- W2089925954 countsByYear W20899259542017 @default.
- W2089925954 countsByYear W20899259542019 @default.
- W2089925954 countsByYear W20899259542020 @default.
- W2089925954 countsByYear W20899259542021 @default.
- W2089925954 countsByYear W20899259542022 @default.
- W2089925954 countsByYear W20899259542023 @default.
- W2089925954 crossrefType "journal-article" @default.
- W2089925954 hasAuthorship W2089925954A5017379947 @default.
- W2089925954 hasAuthorship W2089925954A5018432685 @default.
- W2089925954 hasAuthorship W2089925954A5020254907 @default.
- W2089925954 hasAuthorship W2089925954A5023282286 @default.
- W2089925954 hasAuthorship W2089925954A5026180389 @default.
- W2089925954 hasAuthorship W2089925954A5040938888 @default.
- W2089925954 hasAuthorship W2089925954A5044328939 @default.
- W2089925954 hasAuthorship W2089925954A5047019507 @default.
- W2089925954 hasAuthorship W2089925954A5063649167 @default.
- W2089925954 hasAuthorship W2089925954A5073713547 @default.
- W2089925954 hasAuthorship W2089925954A5086165382 @default.
- W2089925954 hasBestOaLocation W20899259542 @default.
- W2089925954 hasConcept C121608353 @default.
- W2089925954 hasConcept C126189478 @default.
- W2089925954 hasConcept C126322002 @default.
- W2089925954 hasConcept C126894567 @default.
- W2089925954 hasConcept C143998085 @default.
- W2089925954 hasConcept C159641895 @default.
- W2089925954 hasConcept C2775930923 @default.
- W2089925954 hasConcept C2777909004 @default.
- W2089925954 hasConcept C2779786085 @default.
- W2089925954 hasConcept C2780091579 @default.
- W2089925954 hasConcept C2780306776 @default.
- W2089925954 hasConcept C2908647359 @default.
- W2089925954 hasConcept C526805850 @default.
- W2089925954 hasConcept C530470458 @default.
- W2089925954 hasConcept C71924100 @default.
- W2089925954 hasConcept C99454951 @default.
- W2089925954 hasConceptScore W2089925954C121608353 @default.
- W2089925954 hasConceptScore W2089925954C126189478 @default.
- W2089925954 hasConceptScore W2089925954C126322002 @default.
- W2089925954 hasConceptScore W2089925954C126894567 @default.
- W2089925954 hasConceptScore W2089925954C143998085 @default.
- W2089925954 hasConceptScore W2089925954C159641895 @default.
- W2089925954 hasConceptScore W2089925954C2775930923 @default.
- W2089925954 hasConceptScore W2089925954C2777909004 @default.
- W2089925954 hasConceptScore W2089925954C2779786085 @default.
- W2089925954 hasConceptScore W2089925954C2780091579 @default.
- W2089925954 hasConceptScore W2089925954C2780306776 @default.
- W2089925954 hasConceptScore W2089925954C2908647359 @default.
- W2089925954 hasConceptScore W2089925954C526805850 @default.